Humacyte, Inc. (NASDAQ:HUMA) Q1 2026 Earnings Call Transcript May 13, 2026
Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.1.
Operator: Good morning, ladies and gentlemen, and welcome to the Humacyte First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I’ll now turn the call over to Tom Johnson with LifeSci Advisors. Please go ahead, Tom.
Thomas Johnson: Thank you, operator....
